Myfloxin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Myfloxin

Property Description
Active ingredient Norfloxacin
Form Tablet (Oral)
Pharmacological class Fluoroquinolone Antibiotic
General purpose Anti-infective agent for bacterial infections
Origin Synthetic

What is Myfloxin and What Type of Antibiotic is it?

Myfloxin is a specific prescription-only brand containing the synthetic active compound Norfloxacin, which functions as a potent anti-bacterial agent to resolve infections. This drug belongs to the comprehensive quinolone antimicrobial family, more specifically categorized as a first-generation fluoroquinolone. Norfloxacin is an established antimicrobial agent within this class.

The core identity of this medicine is defined by its active ingredient, Norfloxacin, a synthetic molecule characterized by a chemical structure that enhances its activity against many organisms. As a single-ingredient product, Myfloxin is typically formulated as an oral tablet for systemic effect, though Norfloxacin is also available in sterile aqueous solutions for ophthalmic use. The fluoroquinolone family, to which Norfloxacin belongs, is clinically recognized for being effective against a variety of bacteria responsible for causing illness.

How Does the Active Ingredient Norfloxacin Work?

The primary action of Norfloxacin is definitively bactericidal, meaning it directly kills harmful bacteria rather than merely inhibiting their growth. This potent anti-infective property is achieved by selectively disrupting the essential processes responsible for managing bacterial DNA replication and repair. This mechanism is effective against susceptible organisms.

Norfloxacin interferes with two specific bacterial enzymes, DNA gyrase and Topoisomerase IV, which are vital for a bacterial cell's ability to maintain and copy its genetic material. By inhibiting these enzymes, the drug promotes the rapid and definitive cessation of bacterial proliferation. The general purpose of this action is to reduce the bacterial load, thereby assisting the body in overcoming the infection and leading to the resolution of the associated illness, such as a localized bacterial presence.

Regulatory References

  1. U.S. National Library of Medicine, MedlinePlus Drug Information

What side effects are possible with Myfloxin?

Possible Side Effects and Safety Information

The safety profile for Myfloxin, which contains Norfloxacin, is defined by regulatory documents that classify potential adverse reactions across various body systems. Most commonly documented side effects primarily involve the gastrointestinal system (such as nausea and mild diarrhea) and the central nervous system (including headache and dizziness), classified as Common in official records.


Serious and Potentially Irreversible Adverse Reactions

The label documents specific serious adverse reactions associated with this class of antibiotic. These reactions may be disabling and potentially permanent, sometimes manifesting soon after starting treatment or months after therapy is complete. Key concerns officially noted include:

  • Tendonopathy and Tendon Rupture: Damage to tendons, including the Achilles tendon, which can be severe.
  • Peripheral Neuropathy: Nerve damage symptoms (pain, burning, numbness, or weakness) which may be prolonged.
  • Cardiac Events: Risk of QTc prolongation that can lead to potentially life-threatening irregular heart rhythms.
  • Hepatobiliary Disorders: Documentation of severe reactions, including hepatic failure.

Safety Considerations for Specific Populations

Official prescribing information includes specific safety constraints for certain patient groups. Older adults and individuals who have received organ transplants have a documented increased risk of tendon damage. The safety and effectiveness of Norfloxacin have not been established in pediatric patients (under 18). The medicine is also restricted in patients with Myasthenia Gravis due to the risk of exacerbating muscle weakness. Furthermore, regulatory documents specify that concurrent use with systemic corticosteroids increases the risk of tendon rupture and that caution is necessary in patients with existing CNS disorders.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents specify that if Myfloxin (Norfloxacin) overdosage is suspected, it is mandatory to seek immediate medical attention. This action is required because no specific antidote is known for Norfloxacin poisoning, necessitating prompt medical management.


Documented Overdose Manifestations

Acute overdosage may present with several documented clinical features. These often include non-specific gastrointestinal symptoms such as vomiting and diarrhea. Central nervous system effects such as drowsiness, dizziness, confusion, and in severe cases, convulsions, have been reported. A specific physiological finding is crystalluria (crystals in the urine), which is associated with overdosage.


Required Medical Management

Management focuses on supportive care. Due to the risk of crystalluria, patients must maintain adequate hydration, and close renal function monitoring is required during observation. Severe poisoning carries the documented risk of complications, including potential acute renal failure and liver damage. Patients with pre-existing renal impairment are anticipated to experience more pronounced effects from an overdose. Treatment procedures may involve symptomatic and supportive care, and measures such as gastric lavage or induction of emesis may be considered to limit absorption.

Therapeutic Uses of Myfloxin

Myfloxin: Main Uses and Therapeutic Benefits

Myfloxin is used in situations involving certain distressing symptoms, where additional symptomatic support is needed for acute presentations. The medication is considered relevant for easing symptoms in areas where short-term symptomatic assistance is needed. It is applied in areas associated with the approved therapeutic domains.


Symptom Domains and Conditions

Myfloxin helps address symptom clusters that may become intense or disruptive across various clinical domains. This includes managing discomfort associated with conditions presenting with acute episodes that involve symptoms linked to organ-specific functional stress in the respiratory system, and symptoms that create noticeable physiological strain in the skin and internal regions. It is relevant in contexts marked by increased discomfort or tension, applied during phases when symptoms become more noticeable.


Patient-Oriented Benefit

By providing supportive relief, Myfloxin contributes to improved comfort during periods of heightened symptoms and assists with maintaining functional stability when acute manifestations disrupt routine activities. This supportive use contributes to easing the overall symptom load during difficult episodes.

Quick Fact: Relief for Symptoms that Interfere with Daily Functioning

Eligibility and Restrictions for Use

Official Eligibility Rules for Myfloxin (Norfloxacin)

Myfloxin is licensed for use only in the adult population (18 years and older). Eligibility is strictly defined by regulatory documents, excluding or restricting use based on age, pre-existing conditions, and physiological status.


Populations For Whom Use Is Contraindicated

The medicine must not be used in patients with a history of hypersensitivity or allergic reaction to Norfloxacin or any other drug in the quinolone antimicrobial class. It is also contraindicated for individuals with a history of tendonitis or tendon rupture related to quinolone use, or those with known Myasthenia Gravis.


Populations with Conditional or Restricted Eligibility

Population Category Regulatory Status
Pediatric Population (Under 18) Not Recommended/Contraindicated; safety not established, prohibited if epiphyseal closure has not occurred.
Pregnant Women Not Recommended; generally contraindicated, only permitted if clinical benefit outweighs documented risk.
Breastfeeding Women Contraindicated; nursing must be discontinued.
Severe Renal Impairment Restricted Use; requires a mandatory dosage adjustment.
High-Risk Comorbidities Use with Caution in patients with predisposing factors for seizures, QTc prolongation, or those with a history of organ transplant or specific tendon disorders.

What should I know about interactions with other medicines?

Myfloxin Interactions with other medicines and products

Myfloxin (Norfloxacin) interacts with several other medicines and products, necessitating specific constraints as defined in official regulatory labeling.

Interaction-Related Restrictions

Classification Interacting Product or Class
Contraindicated Tizanidine
Use Not Recommended Mycophenolate Mofetil

Co-administration of Tizanidine is prohibited because it significantly increases Tizanidine exposure. The concurrent use of Mycophenolate Mofetil is not recommended due to interference with its internal recirculation.

Exposure and Timing Constraints

Myfloxin may alter the plasma concentrations of certain co-administered agents. Regulatory information states that levels of Theophylline and Cyclosporine may be increased, requiring close monitoring. A clinically significant pharmacodynamic interaction exists with Warfarin and its derivatives, potentially enhancing the anticoagulant effect and necessitating frequent Prothrombin Time/INR checks.

To prevent a substantial reduction in Myfloxin absorption, products containing polyvalent cations, such as antacids (magnesium/aluminum), Sucralfate, Ferrous salts/Iron, and Zinc supplements, must be taken at least two hours before or two hours after the Myfloxin tablet. Similarly, the absorption of Norfloxacin is reduced by dairy products, requiring administration separation.

Mechanism of Action

How Myfloxin Works

Molecular Mechanism: DNA Replication Interference

The mechanism of action for Myfloxin (Norfloxacin) is based on a specific and lethal interference with the essential genetic maintenance machinery of susceptible bacteria. Norfloxacin functions as a DNA Gyrase (Topoisomerase II) and Topoisomerase IV inhibitor and poison . These bacterial enzymes are necessary for managing the structure and separation of the bacterial chromosome during replication. Norfloxacin locks the enzymes onto the DNA strands at the point of breakage, stabilizing a transient covalent complex.


Causal Cascade and Physiological Consequence

This drug-enzyme binding rapidly leads to the accumulation of irreversible DNA double-strand breaks inside the bacteria, causing catastrophic genetic damage. The resulting failure of the DNA replication pathway triggers the cell's demise, resulting in a swift bactericidal effect—the direct killing of the bacterial cells. This lethal mechanism determines the physiological consequence of bacterial cell death.


️ Functional Limitations

The function of this mechanism is constrained by the bacteria’s capacity for genetic change. Mutations in the enzyme genes ( gyrA and parC) can reduce the drug's binding affinity, and the presence of efflux pumps can physically expel the Norfloxacin molecule, preventing it from reaching the necessary lethal concentration at its intracellular targets.

Dosage and Administration Information

How Myfloxin is Used: Administration Guidelines

Myfloxin (Norfloxacin) is an anti-infective agent used according to established guidelines. This section details the instructions for administration, dosing, and duration.


Dosing and Route of Administration

Administration Component Guideline
Route of Administration Myfloxin is for oral administration only.
Standard Adult Dose The typical dose is 400 mg per administration.
Frequency Doses are generally taken twice daily (every 12 hours).

Administration Instructions and Duration

Proper timing is essential for the medication's absorption. The tablet must be swallowed whole with a glass of water and must not be crushed or chewed.

  • Timing: Take the tablet on an empty stomach—specifically, at least one hour before or two hours after consuming any meal, milk, or other dairy products.
  • Absorption Interference: To ensure the drug is absorbed correctly, administration must be separated by at least two hours from metal-containing antacids, sucralfate, or mineral supplements (such as iron or zinc).
  • Course Duration: The length of treatment is determined by the prescriber and varies based on the condition, ranging from a few days (e.g., 3 days for acute cystitis) to extended regimens (e.g., up to 42 days for prostatitis).

Adjustments for Specific Populations

While no dosage change is required for older adults solely based on age, an adjustment is required for reduced kidney function. Patients with marked renal impairment (Creatinine Clearance 30 mL/min/1.73 m^2) typically require a reduced frequency of 400 mg once daily.

Recent Clinical Evidence

Evidence for Use in Uncomplicated Urinary Tract Infections (UTI)

Norfloxacin was studied for use in uncomplicated urinary tract infections. This evidence is largely derived from short-term Randomized Controlled Trials (RCTs), primarily applied in research exploring how symptoms change over time in non-pregnant adults. The main goal of these trials was to monitor the resolution of symptoms and to measure the clearance of specific bacteria, known as bacteriological cure. Early trials reported patterns where a high proportion of participants met criteria for the measured endpoints shortly after the treatment course ended. However, the applicability of this research today is challenged by rising rates of bacterial resistance to fluoroquinolones, and follow-up durations were limited, providing restricted insight into how often symptoms might return over several months.


Evidence for Preventing Infection in Cirrhosis (Prophylaxis)

The role of Norfloxacin was also evaluated in patients with advanced liver disease, specifically those at high risk for Spontaneous Bacterial Peritonitis (SBP). These long-term Randomized Controlled Trials monitored patients over extended intervals, examining the incidence rate of SBP and measurements related to patient survival. Trials reported patterns where a lower incidence of SBP was noted in the Norfloxacin group compared to groups receiving a placebo. Despite these findings, certainty remains low regarding the sustained long-term outcomes. Comparative evidence is lacking, making it difficult to fully contextualize the drug's current standing against newer, guideline-recommended agents for this long-term prophylactic use.


Research Context and Uncertainty

Evidence for other conditions, such as prostatitis and uncomplicated gonorrhea, is based on initial clinical trials that explored microbiological clearance. However, the clinical applicability of this older data is now highly uncertain due to the widespread rise in antibiotic resistance. Overall, data for certain groups remain insufficient, including vulnerable populations such as children or pregnant individuals, as the majority of research was observed in the general adult population. The results apply only to the populations studied, and the data do not provide robust comparisons against other treatments in use today.

Key Studies & References

  1. DailyMed - NORFLOXACIN tablet (Initial regulatory and indication summary)

Frequently Asked Questions (FAQ)

Common questions about Myfloxin (FAQ)

Q: What is Myfloxin used for besides the main condition?

According to official regulatory prescribing information, Myfloxin (Norfloxacin) is approved by health authorities for treating specific bacterial infections. These typically include certain urinary tract infections (UTI), prostatitis, and uncomplicated gonorrhea, as listed in the Indications and Usage section of the labeling.

Q: Can Myfloxin cause long-term side effects?

Yes, regulatory documents note that this class of medicine is associated with serious, disabling, and potentially permanent side effects. These effects can involve the tendons, muscles, joints, nerves (peripheral neuropathy), and the central nervous system. These reactions may manifest shortly after starting treatment or, in some cases, months after the therapy is complete.

Q: Does Myfloxin interact with common supplements like Vitamin D or magnesium?

Regulatory information indicates that Myfloxin can interact with products containing polyvalent cations, such as magnesium (often found in antacids and some supplements) or zinc supplements. Regulatory guidelines state that these supplements should be separated by at least two hours from Myfloxin to ensure the drug’s proper absorption.

Q: Can Myfloxin be taken by people with kidney issues?

Yes, but official guidelines mandate caution and dosage adjustments for individuals with reduced kidney function. Patients with marked renal impairment typically require a mandatory dosage adjustment, such as a reduced frequency of administration, as defined in the prescribing information.

Q: Are there any specific foods or drinks to avoid while taking Myfloxin?

Official prescribing information describes that Myfloxin administration should occur on an empty stomach: at least one hour before or two hours after a meal. Additionally, dairy products, including milk, must be separated from the medication by at least two hours, as they can interfere with drug absorption.

Q: Do older adults react differently to Myfloxin than younger people?

Official labeling states that no dosage change is required for older adults solely based on age. However, older adults do have a documented increased risk of experiencing some serious side effects, such as tendon damage, when compared to younger individuals.

Q: Is Myfloxin safe to use for people who have heart conditions?

Regulatory warnings advise caution for people with a history of or predisposing factors for QTc prolongation. This is a condition that affects heart rhythm, as this class of drug is associated with potential cardiac events. Information regarding the use of Myfloxin in all different types of heart conditions is not comprehensively provided in the product labeling.

Q: Does Myfloxin affect liver function tests?

Yes, the official adverse reaction data notes the potential for Hepatobiliary Disorders. These can include elevations in liver enzymes (like ALT or AST) and severe reactions like hepatic failure, indicating an effect on liver function.

Q: Are there different forms of Myfloxin (e.g., tablet, liquid)?

The Myfloxin brand is typically supplied by the manufacturer as an oral tablet for systemic use. However, the active ingredient Norfloxacin is also available in ophthalmic (eye drop) solutions for specific topical treatments.

Q: Does Myfloxin require special monitoring or blood tests?

If Myfloxin is taken at the same time as certain other medicines, such as Theophylline or Warfarin, special monitoring is required. This can involve blood level checks or frequent Prothrombin Time/INR checks to manage potential drug interactions.

Q: How quickly does Myfloxin start to work after taking it?

Pharmacokinetic studies cited in official labeling show that Myfloxin is rapidly absorbed into the bloodstream. Mean peak plasma concentrations, which are necessary for the drug to begin its action, are typically reached approximately one hour after dosing.

Q: How long does Myfloxin stay in your system?

The effective half-life of Myfloxin (Norfloxacin) in serum and plasma is generally reported as 3 to 4 hours. The half-life refers to the time it takes for half of the drug to be eliminated from the body.

Q: Is it true that Myfloxin can affect sleep patterns?

Yes, adverse reactions reported in regulatory documents include insomnia and other sleep disturbances. These are classified as uncommon Central Nervous System effects associated with the use of the medicine.

Q: Is there a generic version of Myfloxin available?

The active ingredient in the brand-name drug Myfloxin is Norfloxacin. This compound is available from various manufacturers and can be found under different brand names and as a generic formulation.

Q: Why do some people say Myfloxin makes them feel anxious?

Anxiety is listed in regulatory documentation as an uncommon adverse reaction involving the central nervous system. This is a recognized potential side effect associated with the use of this medicine.

Q: What should I do if I miss a time I was supposed to take Myfloxin?

Official dosing guidelines state that for full effectiveness, the drug should be taken at regular intervals, typically every 12 hours. Specific procedures for a missed dose are not uniformly detailed across all official documents.

Q: Is Myfloxin considered a 'strong' medicine?

Myfloxin is scientifically categorized as a potent, bactericidal anti-infective agent. Its mechanism of action is to directly disrupt the DNA replication process of susceptible bacteria, leading to the killing of the bacterial cells.

Q: Can Myfloxin cause weight gain or loss?

Regulatory documents list changes in appetite, including anorexia (loss of appetite), as an uncommon side effect. While the drug is not specifically indicated for weight management, a change in appetite could indirectly influence a patient's weight.

Q: Does Myfloxin affect blood sugar levels?

Yes, the drug class is associated with blood glucose disturbances, also known as dysglycemia. These can include cases of both symptomatic low blood sugar (hypoglycemia) and high blood sugar (hyperglycemia), and caution is advised for patients with diabetes.

Q: Can Myfloxin cause problems with eyesight?

Visual disturbances, including blurred vision, are listed in official documents as uncommon side effects. If vision changes occur while taking this medicine, it should be noted.

Q: Does Myfloxin have a Black Box Warning, and what does it mean?

Yes, Myfloxin is a fluoroquinolone antibiotic, a class that carries the FDA’s most serious warning (Boxed Warning). This warning is related to the risk of disabling and potentially irreversible side effects, particularly tendon rupture and nerve damage.

Q: What happens if Myfloxin is taken for a much longer time than expected?

Official warnings state that taking this drug longer than medically necessary increases the risk of serious side effects. It also increases the potential for the development of drug-resistant bacteria. Dosage should not exceed the duration recommended by the prescriber.

Q: Is it possible to develop a tolerance to Myfloxin over time?

As an antimicrobial agent, the effectiveness of Myfloxin is constrained by the potential for bacteria to develop resistance. This resistance can reduce the drug's efficacy (its ability to work) over time against the target organism.

Q: Does Myfloxin interact with birth control pills?

Official labeling does not specifically list an interaction with hormonal contraceptives. However, it is a general principle that antibiotics may theoretically reduce the effectiveness of some birth control pills.

Q: What should I expect the first few days of taking Myfloxin?

Commonly documented effects that may occur early in therapy include gastrointestinal issues, such as nausea and mild diarrhea. Central Nervous System effects like headache and dizziness are also reported in official records.

Q: Why are there warnings about driving or operating machinery while on Myfloxin?

Warnings are in place because the drug can cause Central Nervous System side effects, such as dizziness, lightheadedness, and confusion. These effects have the potential to impair the judgment and coordination required for driving or operating machinery.

Q: Does alcohol consumption change the way Myfloxin works?

Regulatory information includes statements regarding the concurrent use of alcohol and this medicine, often suggesting limiting or avoiding intake, due to the potential for increased side effects or specific interactions with this drug class.

Q: Are there specific genetic factors that affect how someone responds to Myfloxin?

The official label notes a specific factor: patients with latent or actual defects in Glucose-6-Phosphate Dehydrogenase (G6PD) activity may be at risk of hemolytic reactions (the destruction of red blood cells).

Q: Does Myfloxin make you sensitive to the sun?

Yes, the drug can cause photosensitivity, which is an increased skin sensitivity to sunlight. Due to this risk, official guidance includes recommendations to limit sun exposure, avoid tanning beds, and use protective measures like sunscreen and covering clothing.

Q: Why is Myfloxin often mentioned with a specific warning?

Myfloxin is a fluoroquinolone antibiotic, a class of drugs that is subject to a specific Boxed Warning from health authorities. This warning highlights the significant risk of serious side effects involving the tendons, nerves, and central nervous system.

Q: What are the general expectations for patient improvement on Myfloxin?

Clinical trials for approved uses typically measure improvement through bacteriological cure and symptom resolution shortly after treatment completion. Official documentation emphasizes the importance of completing the full, prescribed course of therapy.

Q: Can Myfloxin be taken with flu or cold medicine?

Many flu and cold medicines, particularly those containing antacids or polyvalent cations (such as iron or zinc), can block Myfloxin's absorption. Official guidelines should be consulted for specific timing separation between the medicines.

Q: Is Myfloxin safe to use before having surgery?

The drug is known to interact with certain medications often involved in pre-surgical care, such as Warfarin, and may affect blood sugar control. Regulatory information confirms the importance of disclosing all medications to health professionals prior to any procedure.

How should Myfloxin be stored and disposed of?

How to Store and Dispose of Myfloxin?

This medication must be stored according to specific regulatory guidelines to maintain its effectiveness. The oral suspension should be kept at Controlled Room Temperature, which is defined as 20^circ to 25 C (68^circ to 77 F), with permitted temperature excursions between 15^circ and 30 C (59^circ and 86 F).

Before administering, the suspension bottle must be shaken well. Always ensure that this product, and all other medicines, is stored out of the reach of children to prevent accidental ingestion.

For disposal, do not flush the medication down the toilet or pour it down a drain unless explicitly instructed to do so. The recommended practice is to dispose of unused or expired Myfloxin by taking it to a drug take-back location or by mixing the contents with an unappealing substance, sealing it in a container, and placing it in household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Myfloxin found in:

A-Z Index: